

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 6.56591826 |
| 2 | muscle filament sliding (GO:0030049) | 6.56591826 |
| 3 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.15386220 |
| 4 | actin-mediated cell contraction (GO:0070252) | 5.59939590 |
| 5 | skeletal muscle contraction (GO:0003009) | 5.13093813 |
| 6 | actin filament-based movement (GO:0030048) | 4.51403988 |
| 7 | NADH metabolic process (GO:0006734) | 4.51108501 |
| 8 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.46989708 |
| 9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.43479419 |
| 10 | skeletal muscle adaptation (GO:0043501) | 4.31094096 |
| 11 | sarcomere organization (GO:0045214) | 4.22469598 |
| 12 | glycogen catabolic process (GO:0005980) | 4.21519367 |
| 13 | striated muscle contraction (GO:0006941) | 4.15945868 |
| 14 | glucan catabolic process (GO:0009251) | 4.00288564 |
| 15 | cellular polysaccharide catabolic process (GO:0044247) | 3.88370441 |
| 16 | cardiac muscle contraction (GO:0060048) | 3.71393786 |
| 17 | regulation of relaxation of muscle (GO:1901077) | 3.69320927 |
| 18 | polysaccharide catabolic process (GO:0000272) | 3.60881922 |
| 19 | myofibril assembly (GO:0030239) | 3.60838589 |
| 20 | synaptic vesicle maturation (GO:0016188) | 3.59043864 |
| 21 | response to muscle activity (GO:0014850) | 3.48253929 |
| 22 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.48123183 |
| 23 | lysine catabolic process (GO:0006554) | 3.46078590 |
| 24 | lysine metabolic process (GO:0006553) | 3.46078590 |
| 25 | pinocytosis (GO:0006907) | 3.34239988 |
| 26 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.33345807 |
| 27 | regulation of skeletal muscle contraction (GO:0014819) | 3.32978423 |
| 28 | actomyosin structure organization (GO:0031032) | 3.30215868 |
| 29 | striated muscle hypertrophy (GO:0014897) | 3.28531276 |
| 30 | macroautophagy (GO:0016236) | 3.28024190 |
| 31 | activation of protein kinase A activity (GO:0034199) | 3.26119395 |
| 32 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.24675075 |
| 33 | fructose metabolic process (GO:0006000) | 3.23819710 |
| 34 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.21737774 |
| 35 | Golgi transport vesicle coating (GO:0048200) | 3.20644396 |
| 36 | COPI coating of Golgi vesicle (GO:0048205) | 3.20644396 |
| 37 | nuclear pore complex assembly (GO:0051292) | 3.20557890 |
| 38 | sodium ion export (GO:0071436) | 3.16379092 |
| 39 | glucan biosynthetic process (GO:0009250) | 3.12976049 |
| 40 | glycogen biosynthetic process (GO:0005978) | 3.12976049 |
| 41 | cardiac muscle hypertrophy (GO:0003300) | 3.08333499 |
| 42 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.07912375 |
| 43 | muscle contraction (GO:0006936) | 3.07891442 |
| 44 | striated muscle adaptation (GO:0014888) | 3.07858247 |
| 45 | regulation of actin filament-based movement (GO:1903115) | 3.03478668 |
| 46 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.01391304 |
| 47 | pentose-phosphate shunt (GO:0006098) | 3.00651012 |
| 48 | alpha-linolenic acid metabolic process (GO:0036109) | 3.00030566 |
| 49 | gluconeogenesis (GO:0006094) | 2.99243136 |
| 50 | glycosphingolipid catabolic process (GO:0046479) | 2.99218383 |
| 51 | cellular potassium ion homeostasis (GO:0030007) | 2.98826775 |
| 52 | locomotory exploration behavior (GO:0035641) | 2.98355597 |
| 53 | muscle hypertrophy (GO:0014896) | 2.95830310 |
| 54 | response to inactivity (GO:0014854) | 2.94913721 |
| 55 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.93480486 |
| 56 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.91335424 |
| 57 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.90815033 |
| 58 | L-phenylalanine catabolic process (GO:0006559) | 2.90815033 |
| 59 | aspartate family amino acid catabolic process (GO:0009068) | 2.89771266 |
| 60 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.89650786 |
| 61 | positive regulation of receptor recycling (GO:0001921) | 2.88982496 |
| 62 | myoblast fusion (GO:0007520) | 2.87973383 |
| 63 | creatine metabolic process (GO:0006600) | 2.87906006 |
| 64 | L-phenylalanine metabolic process (GO:0006558) | 2.85842227 |
| 65 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.85842227 |
| 66 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.85562265 |
| 67 | muscle adaptation (GO:0043500) | 2.85238008 |
| 68 | NADPH regeneration (GO:0006740) | 2.84970496 |
| 69 | COPII vesicle coating (GO:0048208) | 2.84927584 |
| 70 | 2-oxoglutarate metabolic process (GO:0006103) | 2.84886226 |
| 71 | protein localization to endosome (GO:0036010) | 2.84107964 |
| 72 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.83660427 |
| 73 | cardiac myofibril assembly (GO:0055003) | 2.82377397 |
| 74 | muscle atrophy (GO:0014889) | 2.81573199 |
| 75 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.81481251 |
| 76 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.79371845 |
| 77 | regulation of early endosome to late endosome transport (GO:2000641) | 2.77425229 |
| 78 | hexose biosynthetic process (GO:0019319) | 2.77219042 |
| 79 | muscle system process (GO:0003012) | 2.77174552 |
| 80 | glycogen metabolic process (GO:0005977) | 2.75891780 |
| 81 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.75883455 |
| 82 | cell communication by electrical coupling (GO:0010644) | 2.74820125 |
| 83 | striated muscle atrophy (GO:0014891) | 2.74160557 |
| 84 | layer formation in cerebral cortex (GO:0021819) | 2.74050578 |
| 85 | glycolipid catabolic process (GO:0019377) | 2.73665014 |
| 86 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.73023860 |
| 87 | glutamate secretion (GO:0014047) | 2.71768915 |
| 88 | glucan metabolic process (GO:0044042) | 2.71595819 |
| 89 | cellular glucan metabolic process (GO:0006073) | 2.71595819 |
| 90 | AMP metabolic process (GO:0046033) | 2.71590156 |
| 91 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.69516572 |
| 92 | glutamate metabolic process (GO:0006536) | 2.68904628 |
| 93 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.68643657 |
| 94 | regulation of receptor recycling (GO:0001919) | 2.68616453 |
| 95 | histone H3-K36 demethylation (GO:0070544) | 2.68355580 |
| 96 | succinate metabolic process (GO:0006105) | 2.67592010 |
| 97 | tricarboxylic acid metabolic process (GO:0072350) | 2.64281713 |
| 98 | synaptic vesicle exocytosis (GO:0016079) | 2.64260322 |
| 99 | focal adhesion assembly (GO:0048041) | 2.63988525 |
| 100 | cell-substrate adherens junction assembly (GO:0007045) | 2.63988525 |
| 101 | heart contraction (GO:0060047) | 2.62566734 |
| 102 | heart process (GO:0003015) | 2.62566734 |
| 103 | protein targeting to Golgi (GO:0000042) | 2.62440039 |
| 104 | monosaccharide biosynthetic process (GO:0046364) | 2.62388926 |
| 105 | neutrophil activation involved in immune response (GO:0002283) | 2.62154918 |
| 106 | pore complex assembly (GO:0046931) | 2.61547897 |
| 107 | epithelial cell-cell adhesion (GO:0090136) | 2.61132565 |
| 108 | regulation of cholesterol homeostasis (GO:2000188) | 2.59874769 |
| 109 | regulation of ARF protein signal transduction (GO:0032012) | 2.59714188 |
| 110 | potassium ion import (GO:0010107) | 2.58544950 |
| 111 | fatty acid transmembrane transport (GO:1902001) | 2.58350626 |
| 112 | response to thyroid hormone (GO:0097066) | 2.58234186 |
| 113 | plasma membrane repair (GO:0001778) | 2.57908886 |
| 114 | neurotransmitter secretion (GO:0007269) | 2.57407965 |
| 115 | cellular protein complex localization (GO:0034629) | 2.57085216 |
| 116 | nucleotide salvage (GO:0043173) | 2.56439460 |
| 117 | nuclear pore organization (GO:0006999) | 2.56359752 |
| 118 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.55945723 |
| 119 | regulation of cell communication by electrical coupling (GO:0010649) | 2.54879009 |
| 120 | fatty acid homeostasis (GO:0055089) | 2.53753505 |
| 121 | establishment of protein localization to Golgi (GO:0072600) | 2.51154892 |
| 122 | carnitine shuttle (GO:0006853) | 2.50014620 |
| 123 | proline transport (GO:0015824) | 2.49717426 |
| 124 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.49458439 |
| 125 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.49429501 |
| 126 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.49371120 |
| 127 | cysteine metabolic process (GO:0006534) | 2.49175670 |
| 128 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.48809102 |
| 129 | cell communication involved in cardiac conduction (GO:0086065) | 2.47275682 |
| 130 | barbed-end actin filament capping (GO:0051016) | 2.47263906 |
| 131 | dicarboxylic acid catabolic process (GO:0043649) | 2.47229897 |
| 132 | cerebellar Purkinje cell layer development (GO:0021680) | 2.46607459 |
| 133 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.45705202 |
| 134 | 4-hydroxyproline metabolic process (GO:0019471) | 2.45704014 |
| 135 | vesicle transport along microtubule (GO:0047496) | 2.44017597 |
| 136 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.43568274 |
| 137 | IMP metabolic process (GO:0046040) | 2.43110085 |
| 138 | adherens junction assembly (GO:0034333) | 2.42854331 |
| 139 | negative regulation of necroptotic process (GO:0060546) | 2.42633945 |
| 140 | skeletal muscle fiber development (GO:0048741) | 2.42334224 |
| 141 | histone H3-K9 demethylation (GO:0033169) | 2.41956783 |
| 142 | positive regulation of glycolytic process (GO:0045821) | 2.41814510 |
| 143 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.41616017 |
| 144 | oxaloacetate metabolic process (GO:0006107) | 2.39700302 |
| 145 | cellular sodium ion homeostasis (GO:0006883) | 2.39533020 |
| 146 | oligosaccharide catabolic process (GO:0009313) | 2.39376699 |
| 147 | glucose catabolic process (GO:0006007) | 2.38769088 |
| 148 | alanine transport (GO:0032328) | 2.38686807 |
| 149 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.37456426 |
| 150 | glycine transport (GO:0015816) | 2.35693408 |
| 151 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.35504270 |
| 152 | acylglycerol catabolic process (GO:0046464) | 2.33340146 |
| 153 | neutral lipid catabolic process (GO:0046461) | 2.33340146 |
| 154 | regulation of synapse structural plasticity (GO:0051823) | 2.32431453 |
| 155 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.31293005 |
| 156 | regulation of synaptic vesicle transport (GO:1902803) | 2.31201334 |
| 157 | drug transmembrane transport (GO:0006855) | 2.31177333 |
| 158 | cellular modified amino acid catabolic process (GO:0042219) | 2.30405367 |
| 159 | low-density lipoprotein particle clearance (GO:0034383) | 2.30021623 |
| 160 | cellular ketone body metabolic process (GO:0046950) | 2.29786852 |
| 161 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.28378522 |
| 162 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.28341640 |
| 163 | short-chain fatty acid metabolic process (GO:0046459) | 2.27614835 |
| 164 | valine metabolic process (GO:0006573) | 2.27212312 |
| 165 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.26641648 |
| 166 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.24768072 |
| 167 | positive regulation of nuclease activity (GO:0032075) | 2.24546280 |
| 168 | sulfur amino acid catabolic process (GO:0000098) | 2.23758973 |
| 169 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.23514488 |
| 170 | drug catabolic process (GO:0042737) | 2.23383541 |
| 171 | neuromuscular process controlling posture (GO:0050884) | 2.22505528 |
| 172 | nerve growth factor signaling pathway (GO:0038180) | 2.22014966 |
| 173 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.20874971 |
| 174 | amino-acid betaine transport (GO:0015838) | 2.19817648 |
| 175 | carnitine transport (GO:0015879) | 2.19817648 |
| 176 | membrane repolarization (GO:0086009) | 2.19152844 |
| 177 | negative regulation of cell size (GO:0045792) | 2.19059418 |
| 178 | neuromuscular process controlling balance (GO:0050885) | 2.18853402 |
| 179 | potassium ion homeostasis (GO:0055075) | 2.18443417 |
| 180 | acetyl-CoA metabolic process (GO:0006084) | 2.18225001 |
| 181 | regulation of fatty acid oxidation (GO:0046320) | 2.15126620 |
| 182 | tricarboxylic acid cycle (GO:0006099) | 2.12514836 |
| 183 | phosphate ion transport (GO:0006817) | 2.11711314 |
| 184 | endoplasmic reticulum organization (GO:0007029) | 2.11053934 |
| 185 | triglyceride catabolic process (GO:0019433) | 2.10302166 |
| 186 | aromatic amino acid family catabolic process (GO:0009074) | 2.10116623 |
| 187 | carnitine transmembrane transport (GO:1902603) | 2.09964709 |
| 188 | neuronal action potential propagation (GO:0019227) | 2.09837837 |
| 189 | membrane repolarization during action potential (GO:0086011) | 2.09452517 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.66895791 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.79126730 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.73508939 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.72997515 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.48078430 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.45079148 |
| 7 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.41336072 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.37731937 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.32082825 |
| 10 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.27163109 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.23725754 |
| 12 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.12150390 |
| 13 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.02609314 |
| 14 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.01552972 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.01363909 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.94910738 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.92020790 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.91725742 |
| 19 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.89138855 |
| 20 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.88890009 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.85522267 |
| 22 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.79711939 |
| 23 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.77318463 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.75606172 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.72597303 |
| 26 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.72583399 |
| 27 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.71774936 |
| 28 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.71345046 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.61067242 |
| 30 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.60503615 |
| 31 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60267688 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.59972867 |
| 33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.59247484 |
| 34 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.58486495 |
| 35 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.58396423 |
| 36 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.57354654 |
| 37 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.56809233 |
| 38 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.56179846 |
| 39 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.55538199 |
| 40 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.53348920 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.52964487 |
| 42 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.50196714 |
| 43 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.47543827 |
| 44 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.47297560 |
| 45 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.44742862 |
| 46 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.44617148 |
| 47 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.44333471 |
| 48 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.44000458 |
| 49 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.44000458 |
| 50 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.43641578 |
| 51 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43243004 |
| 52 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.41867248 |
| 53 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.41202353 |
| 54 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.40781956 |
| 55 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.38681990 |
| 56 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.37898182 |
| 57 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.36654901 |
| 58 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.35402476 |
| 59 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34443928 |
| 60 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.33817811 |
| 61 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.33354248 |
| 62 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.31316574 |
| 63 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29897063 |
| 64 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.29568421 |
| 65 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.28722519 |
| 66 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.28186981 |
| 67 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.27825782 |
| 68 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.27596818 |
| 69 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.26093571 |
| 70 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.25782263 |
| 71 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.25752684 |
| 72 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.25752684 |
| 73 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.25740531 |
| 74 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.25152242 |
| 75 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.23763046 |
| 76 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22629006 |
| 77 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.22386478 |
| 78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21337695 |
| 79 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.21128766 |
| 80 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.19888228 |
| 81 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.18712085 |
| 82 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.17990550 |
| 83 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17180464 |
| 84 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.16977899 |
| 85 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16328161 |
| 86 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15820867 |
| 87 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.15641250 |
| 88 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.15566688 |
| 89 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.15306166 |
| 90 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.14728417 |
| 91 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14661062 |
| 92 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13266272 |
| 93 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.13057676 |
| 94 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.12105752 |
| 95 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.11495735 |
| 96 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.11414953 |
| 97 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.11369694 |
| 98 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.10973775 |
| 99 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10846693 |
| 100 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.09740743 |
| 101 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.09689362 |
| 102 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.09562109 |
| 103 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.08839074 |
| 104 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.08595059 |
| 105 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.08595059 |
| 106 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.08429537 |
| 107 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.08105060 |
| 108 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.08005671 |
| 109 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07640514 |
| 110 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06305957 |
| 111 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.06215459 |
| 112 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.06181473 |
| 113 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05665840 |
| 114 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.05417874 |
| 115 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.05206986 |
| 116 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.05199256 |
| 117 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.04411685 |
| 118 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.03891105 |
| 119 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.03740946 |
| 120 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.03660424 |
| 121 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03351807 |
| 122 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.02017749 |
| 123 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.01536214 |
| 124 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.01503459 |
| 125 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.00343422 |
| 126 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.99161628 |
| 127 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.98573423 |
| 128 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.98053068 |
| 129 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.98034374 |
| 130 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.97095245 |
| 131 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96769331 |
| 132 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.95547615 |
| 133 | * AR_19668381_ChIP-Seq_PC3_Human | 0.95414423 |
| 134 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.94676263 |
| 135 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94512639 |
| 136 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.94084520 |
| 137 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.93228015 |
| 138 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93176069 |
| 139 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.92510042 |
| 140 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.92353653 |
| 141 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91001235 |
| 142 | ATF3_27146783_Chip-Seq_COLON_Human | 0.90368302 |
| 143 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90054155 |
| 144 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.89950244 |
| 145 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89782167 |
| 146 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88285579 |
| 147 | RXR_22108803_ChIP-Seq_LS180_Human | 0.88116333 |
| 148 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88021604 |
| 149 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.87759685 |
| 150 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.87314577 |
| 151 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.86716376 |
| 152 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.85966744 |
| 153 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.85261921 |
| 154 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.83421762 |
| 155 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83376526 |
| 156 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.82614339 |
| 157 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.82532403 |
| 158 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.82197017 |
| 159 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.81884172 |
| 160 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.81688555 |
| 161 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.81080017 |
| 162 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80486305 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 3.58826201 |
| 2 | MP0005451_abnormal_body_composition | 3.55358498 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.40126576 |
| 4 | MP0005360_urolithiasis | 3.16089760 |
| 5 | MP0002909_abnormal_adrenal_gland | 2.92945580 |
| 6 | MP0004130_abnormal_muscle_cell | 2.54490143 |
| 7 | MP0005365_abnormal_bile_salt | 2.51919295 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 2.47697622 |
| 9 | MP0009780_abnormal_chondrocyte_physiolo | 2.43851459 |
| 10 | MP0010352_gastrointestinal_tract_polyps | 2.43704414 |
| 11 | MP0010234_abnormal_vibrissa_follicle | 2.36103727 |
| 12 | MP0002837_dystrophic_cardiac_calcinosis | 2.33772687 |
| 13 | MP0002332_abnormal_exercise_endurance | 2.25378801 |
| 14 | MP0003252_abnormal_bile_duct | 2.17907534 |
| 15 | MP0000759_abnormal_skeletal_muscle | 2.16076547 |
| 16 | MP0003195_calcinosis | 2.13628852 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 2.13011134 |
| 18 | MP0003283_abnormal_digestive_organ | 2.12334595 |
| 19 | MP0004043_abnormal_pH_regulation | 2.11751596 |
| 20 | MP0000013_abnormal_adipose_tissue | 2.04555785 |
| 21 | MP0004270_analgesia | 2.04455655 |
| 22 | MP0003635_abnormal_synaptic_transmissio | 1.97412557 |
| 23 | MP0003300_gastrointestinal_ulcer | 1.96159209 |
| 24 | MP0003329_amyloid_beta_deposits | 1.95911890 |
| 25 | MP0002822_catalepsy | 1.92961636 |
| 26 | MP0010329_abnormal_lipoprotein_level | 1.85998943 |
| 27 | MP0008961_abnormal_basal_metabolism | 1.85743508 |
| 28 | MP0008875_abnormal_xenobiotic_pharmacok | 1.82554467 |
| 29 | MP0003566_abnormal_cell_adhesion | 1.81930305 |
| 30 | MP0005083_abnormal_biliary_tract | 1.81361647 |
| 31 | MP0002972_abnormal_cardiac_muscle | 1.79585064 |
| 32 | MP0002106_abnormal_muscle_physiology | 1.78684876 |
| 33 | MP0000751_myopathy | 1.73038787 |
| 34 | MP0010630_abnormal_cardiac_muscle | 1.66767568 |
| 35 | MP0004185_abnormal_adipocyte_glucose | 1.60996630 |
| 36 | MP0001661_extended_life_span | 1.60307608 |
| 37 | MP0010678_abnormal_skin_adnexa | 1.55707635 |
| 38 | MP0000747_muscle_weakness | 1.55002120 |
| 39 | MP0005332_abnormal_amino_acid | 1.50301544 |
| 40 | MP0001666_abnormal_nutrient_absorption | 1.49940279 |
| 41 | MP0004858_abnormal_nervous_system | 1.49883963 |
| 42 | MP0000003_abnormal_adipose_tissue | 1.48469398 |
| 43 | MP0004510_myositis | 1.48408366 |
| 44 | MP0004036_abnormal_muscle_relaxation | 1.47817659 |
| 45 | MP0005666_abnormal_adipose_tissue | 1.47346494 |
| 46 | MP0000733_abnormal_muscle_development | 1.46211694 |
| 47 | MP0000604_amyloidosis | 1.44174781 |
| 48 | MP0002118_abnormal_lipid_homeostasis | 1.44020750 |
| 49 | MP0003453_abnormal_keratinocyte_physiol | 1.43779619 |
| 50 | MP0002877_abnormal_melanocyte_morpholog | 1.42644736 |
| 51 | MP0005058_abnormal_lysosome_morphology | 1.42509728 |
| 52 | MP0003950_abnormal_plasma_membrane | 1.40838497 |
| 53 | MP0005369_muscle_phenotype | 1.40564807 |
| 54 | MP0002063_abnormal_learning/memory/cond | 1.40466221 |
| 55 | MP0005375_adipose_tissue_phenotype | 1.40152087 |
| 56 | MP0006138_congestive_heart_failure | 1.40080614 |
| 57 | MP0002064_seizures | 1.39563581 |
| 58 | MP0005535_abnormal_body_temperature | 1.38522631 |
| 59 | MP0005165_increased_susceptibility_to | 1.38103035 |
| 60 | MP0000750_abnormal_muscle_regeneration | 1.36814140 |
| 61 | MP0003828_pulmonary_edema | 1.36257095 |
| 62 | MP0002078_abnormal_glucose_homeostasis | 1.35414195 |
| 63 | MP0003941_abnormal_skin_development | 1.34105531 |
| 64 | MP0009745_abnormal_behavioral_response | 1.32707062 |
| 65 | MP0004145_abnormal_muscle_electrophysio | 1.32594571 |
| 66 | MP0003690_abnormal_glial_cell | 1.30804374 |
| 67 | MP0004084_abnormal_cardiac_muscle | 1.30336399 |
| 68 | MP0004484_altered_response_of | 1.28647001 |
| 69 | MP0001765_abnormal_ion_homeostasis | 1.28197361 |
| 70 | MP0003221_abnormal_cardiomyocyte_apopto | 1.27288150 |
| 71 | MP0005167_abnormal_blood-brain_barrier | 1.27212891 |
| 72 | MP0003045_fibrosis | 1.26985190 |
| 73 | MP0003633_abnormal_nervous_system | 1.25885993 |
| 74 | MP0002796_impaired_skin_barrier | 1.24984493 |
| 75 | MP0009046_muscle_twitch | 1.22998763 |
| 76 | MP0009840_abnormal_foam_cell | 1.22344510 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 1.18921591 |
| 78 | MP0001501_abnormal_sleep_pattern | 1.18329581 |
| 79 | MP0002269_muscular_atrophy | 1.16073016 |
| 80 | MP0000343_altered_response_to | 1.14857130 |
| 81 | MP0005409_darkened_coat_color | 1.14463518 |
| 82 | MP0002166_altered_tumor_susceptibility | 1.13540457 |
| 83 | MP0003172_abnormal_lysosome_physiology | 1.12892635 |
| 84 | MP0003646_muscle_fatigue | 1.12408604 |
| 85 | MP0004264_abnormal_extraembryonic_tissu | 1.12328626 |
| 86 | MP0009672_abnormal_birth_weight | 1.11052450 |
| 87 | MP0004215_abnormal_myocardial_fiber | 1.10558306 |
| 88 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09674441 |
| 89 | MP0009643_abnormal_urine_homeostasis | 1.08755979 |
| 90 | MP0004233_abnormal_muscle_weight | 1.08347282 |
| 91 | MP0004087_abnormal_muscle_fiber | 1.08153856 |
| 92 | MP0005623_abnormal_meninges_morphology | 1.06559702 |
| 93 | MP0008260_abnormal_autophagy | 1.06148591 |
| 94 | MP0002090_abnormal_vision | 1.05604839 |
| 95 | MP0003191_abnormal_cellular_cholesterol | 1.05535247 |
| 96 | MP0002733_abnormal_thermal_nociception | 1.04678170 |
| 97 | MP0002272_abnormal_nervous_system | 1.03788506 |
| 98 | MP0005377_hearing/vestibular/ear_phenot | 1.02544161 |
| 99 | MP0003878_abnormal_ear_physiology | 1.02544161 |
| 100 | MP0001944_abnormal_pancreas_morphology | 1.02177974 |
| 101 | MP0004885_abnormal_endolymph | 1.01800523 |
| 102 | MP0003075_altered_response_to | 1.01663542 |
| 103 | MP0001756_abnormal_urination | 1.00976896 |
| 104 | MP0002971_abnormal_brown_adipose | 1.00490280 |
| 105 | MP0000383_abnormal_hair_follicle | 0.99259596 |
| 106 | MP0005464_abnormal_platelet_physiology | 0.99048934 |
| 107 | MP0002734_abnormal_mechanical_nocicepti | 0.98949631 |
| 108 | MP0002138_abnormal_hepatobiliary_system | 0.97541442 |
| 109 | MP0000609_abnormal_liver_physiology | 0.96997773 |
| 110 | MP0003806_abnormal_nucleotide_metabolis | 0.96929294 |
| 111 | MP0001544_abnormal_cardiovascular_syste | 0.96901446 |
| 112 | MP0005385_cardiovascular_system_phenoty | 0.96901446 |
| 113 | MP0004811_abnormal_neuron_physiology | 0.94766933 |
| 114 | MP0002998_abnormal_bone_remodeling | 0.94657083 |
| 115 | MP0006036_abnormal_mitochondrial_physio | 0.94487997 |
| 116 | MP0001440_abnormal_grooming_behavior | 0.93303507 |
| 117 | MP0002572_abnormal_emotion/affect_behav | 0.93139806 |
| 118 | MP0002693_abnormal_pancreas_physiology | 0.92559234 |
| 119 | MP0001968_abnormal_touch/_nociception | 0.92397759 |
| 120 | MP0008569_lethality_at_weaning | 0.91614254 |
| 121 | MP0003868_abnormal_feces_composition | 0.91143852 |
| 122 | MP0005266_abnormal_metabolism | 0.90467618 |
| 123 | MP0005330_cardiomyopathy | 0.90180712 |
| 124 | MP0005620_abnormal_muscle_contractility | 0.89855765 |
| 125 | MP0002127_abnormal_cardiovascular_syste | 0.86318957 |
| 126 | MP0005670_abnormal_white_adipose | 0.86273495 |
| 127 | MP0005319_abnormal_enzyme/_coenzyme | 0.85834146 |
| 128 | MP0003631_nervous_system_phenotype | 0.85657994 |
| 129 | MP0003091_abnormal_cell_migration | 0.82774214 |
| 130 | MP0005187_abnormal_penis_morphology | 0.82675135 |
| 131 | MP0005166_decreased_susceptibility_to | 0.82464961 |
| 132 | MP0002896_abnormal_bone_mineralization | 0.81708338 |
| 133 | MP0000749_muscle_degeneration | 0.81051202 |
| 134 | MP0008874_decreased_physiological_sensi | 0.80452953 |
| 135 | MP0003183_abnormal_peptide_metabolism | 0.79765870 |
| 136 | MP0005257_abnormal_intraocular_pressure | 0.79553011 |
| 137 | MP0000569_abnormal_digit_pigmentation | 0.79437552 |
| 138 | MP0004924_abnormal_behavior | 0.78488110 |
| 139 | MP0005386_behavior/neurological_phenoty | 0.78488110 |
| 140 | MP0001730_embryonic_growth_arrest | 0.78151200 |
| 141 | MP0003953_abnormal_hormone_level | 0.78059210 |
| 142 | MP0001970_abnormal_pain_threshold | 0.77853065 |
| 143 | MP0002006_tumorigenesis | 0.77209310 |
| 144 | MP0001299_abnormal_eye_distance/ | 0.76836447 |
| 145 | MP0004085_abnormal_heartbeat | 0.76123931 |
| 146 | MP0000230_abnormal_systemic_arterial | 0.76074344 |
| 147 | MP0008775_abnormal_heart_ventricle | 0.75823081 |
| 148 | MP0003879_abnormal_hair_cell | 0.75736581 |
| 149 | MP0002108_abnormal_muscle_morphology | 0.73315582 |
| 150 | MP0010307_abnormal_tumor_latency | 0.73034124 |
| 151 | MP0001727_abnormal_embryo_implantation | 0.72870971 |
| 152 | MP0004272_abnormal_basement_membrane | 0.72729502 |
| 153 | MP0001849_ear_inflammation | 0.71590319 |
| 154 | MP0009115_abnormal_fat_cell | 0.70238347 |
| 155 | MP0002009_preneoplasia | 0.66318101 |
| 156 | MP0000266_abnormal_heart_morphology | 0.64124792 |
| 157 | MP0003448_altered_tumor_morphology | 0.63881955 |
| 158 | MP0001216_abnormal_epidermal_layer | 0.62456135 |
| 159 | MP0004808_abnormal_hematopoietic_stem | 0.61278042 |
| 160 | MP0001853_heart_inflammation | 0.59279622 |
| 161 | MP0000377_abnormal_hair_follicle | 0.57051263 |
| 162 | MP0002086_abnormal_extraembryonic_tissu | 0.55664064 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 7.42702071 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 7.41147981 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.22169616 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 5.26999672 |
| 5 | EMG: myopathic abnormalities (HP:0003458) | 4.39444441 |
| 6 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.32473496 |
| 7 | Distal lower limb muscle weakness (HP:0009053) | 3.95025244 |
| 8 | Increased connective tissue (HP:0009025) | 3.73687097 |
| 9 | Rhabdomyolysis (HP:0003201) | 3.71533731 |
| 10 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.66425307 |
| 11 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.60597377 |
| 12 | Subaortic stenosis (HP:0001682) | 3.60597377 |
| 13 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.59150144 |
| 14 | Distal arthrogryposis (HP:0005684) | 3.58440972 |
| 15 | Muscle fiber splitting (HP:0003555) | 3.54449443 |
| 16 | Neck muscle weakness (HP:0000467) | 3.36463652 |
| 17 | Calf muscle hypertrophy (HP:0008981) | 3.27709514 |
| 18 | Ketoacidosis (HP:0001993) | 3.23691824 |
| 19 | Visual hallucinations (HP:0002367) | 3.14204385 |
| 20 | Increased variability in muscle fiber diameter (HP:0003557) | 3.12039570 |
| 21 | Distal lower limb amyotrophy (HP:0008944) | 3.11528331 |
| 22 | Ventricular tachycardia (HP:0004756) | 3.10516703 |
| 23 | Round ear (HP:0100830) | 3.08350076 |
| 24 | Myopathic facies (HP:0002058) | 3.05428731 |
| 25 | Myokymia (HP:0002411) | 3.03905504 |
| 26 | Rimmed vacuoles (HP:0003805) | 3.02083152 |
| 27 | Abnormality of the calf musculature (HP:0001430) | 3.01807923 |
| 28 | Ulnar deviation of the wrist (HP:0003049) | 2.98421326 |
| 29 | Right ventricular cardiomyopathy (HP:0011663) | 2.94921013 |
| 30 | Gout (HP:0001997) | 2.94411119 |
| 31 | Ketosis (HP:0001946) | 2.86763027 |
| 32 | Hypoglycemic coma (HP:0001325) | 2.83024288 |
| 33 | Xanthomatosis (HP:0000991) | 2.74624655 |
| 34 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.72736094 |
| 35 | Deep venous thrombosis (HP:0002625) | 2.71887172 |
| 36 | Exercise-induced myalgia (HP:0003738) | 2.69321125 |
| 37 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.67923034 |
| 38 | Myoglobinuria (HP:0002913) | 2.66339617 |
| 39 | Action tremor (HP:0002345) | 2.66013914 |
| 40 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.64491777 |
| 41 | Resting tremor (HP:0002322) | 2.61003499 |
| 42 | Progressive muscle weakness (HP:0003323) | 2.59269316 |
| 43 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.54673017 |
| 44 | Focal motor seizures (HP:0011153) | 2.54147148 |
| 45 | Muscle stiffness (HP:0003552) | 2.49262310 |
| 46 | Atrioventricular block (HP:0001678) | 2.48845729 |
| 47 | Scapular winging (HP:0003691) | 2.46343511 |
| 48 | Bundle branch block (HP:0011710) | 2.45430026 |
| 49 | Abnormal atrioventricular conduction (HP:0005150) | 2.44048648 |
| 50 | Heart block (HP:0012722) | 2.42934816 |
| 51 | Intrahepatic cholestasis (HP:0001406) | 2.41492043 |
| 52 | Exercise-induced muscle cramps (HP:0003710) | 2.39911852 |
| 53 | Axonal loss (HP:0003447) | 2.38193845 |
| 54 | Abnormality of the lower motor neuron (HP:0002366) | 2.37536259 |
| 55 | Areflexia of lower limbs (HP:0002522) | 2.35266712 |
| 56 | Focal seizures (HP:0007359) | 2.34310871 |
| 57 | Dysmetric saccades (HP:0000641) | 2.33175404 |
| 58 | Global brain atrophy (HP:0002283) | 2.32461683 |
| 59 | Dilated cardiomyopathy (HP:0001644) | 2.32080510 |
| 60 | Difficulty running (HP:0009046) | 2.29797550 |
| 61 | Lipoatrophy (HP:0100578) | 2.28906348 |
| 62 | Hyporeflexia of lower limbs (HP:0002600) | 2.25948615 |
| 63 | Hypoglycemic seizures (HP:0002173) | 2.25851711 |
| 64 | Cerebral inclusion bodies (HP:0100314) | 2.25798717 |
| 65 | Abnormality of the Achilles tendon (HP:0005109) | 2.23935703 |
| 66 | Distal upper limb amyotrophy (HP:0007149) | 2.18637568 |
| 67 | Upper limb amyotrophy (HP:0009129) | 2.18637568 |
| 68 | Supranuclear gaze palsy (HP:0000605) | 2.18554611 |
| 69 | Depression (HP:0000716) | 2.18021675 |
| 70 | Bulbar palsy (HP:0001283) | 2.17458730 |
| 71 | Ankle clonus (HP:0011448) | 2.16998570 |
| 72 | Hyperglycemia (HP:0003074) | 2.16731732 |
| 73 | Papilledema (HP:0001085) | 2.16434447 |
| 74 | Progressive external ophthalmoplegia (HP:0000590) | 2.15762502 |
| 75 | Postural instability (HP:0002172) | 2.15466111 |
| 76 | Lower limb amyotrophy (HP:0007210) | 2.15304210 |
| 77 | Generalized muscle weakness (HP:0003324) | 2.11575663 |
| 78 | Ragged-red muscle fibers (HP:0003200) | 2.11260274 |
| 79 | EMG: neuropathic changes (HP:0003445) | 2.11112875 |
| 80 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.10668725 |
| 81 | Abnormality of purine metabolism (HP:0004352) | 2.10514284 |
| 82 | Ventricular fibrillation (HP:0001663) | 2.09479055 |
| 83 | Termporal pattern (HP:0011008) | 2.08506889 |
| 84 | Insidious onset (HP:0003587) | 2.08506889 |
| 85 | Skin nodule (HP:0200036) | 2.08357729 |
| 86 | Hyperlipoproteinemia (HP:0010980) | 2.07686920 |
| 87 | Achilles tendon contracture (HP:0001771) | 2.07202469 |
| 88 | Hypoalphalipoproteinemia (HP:0003233) | 2.07049997 |
| 89 | Complement deficiency (HP:0004431) | 2.06117973 |
| 90 | Intention tremor (HP:0002080) | 2.04789630 |
| 91 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.04658802 |
| 92 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.04159499 |
| 93 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.03635473 |
| 94 | Calcaneovalgus deformity (HP:0001848) | 2.03435366 |
| 95 | Sudden death (HP:0001699) | 2.01957952 |
| 96 | Nasal polyposis (HP:0100582) | 2.01079778 |
| 97 | Generalized tonic-clonic seizures (HP:0002069) | 2.00446931 |
| 98 | Abnormality of the nasal mucosa (HP:0000433) | 2.00371106 |
| 99 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.00055383 |
| 100 | Abnormality of glycolipid metabolism (HP:0010969) | 2.00055383 |
| 101 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.00055383 |
| 102 | Pheochromocytoma (HP:0002666) | 1.98290653 |
| 103 | Urinary urgency (HP:0000012) | 1.97211202 |
| 104 | Upper motor neuron abnormality (HP:0002127) | 1.97063641 |
| 105 | Spinal rigidity (HP:0003306) | 1.96857135 |
| 106 | Osteolytic defects of the hand bones (HP:0009699) | 1.94714680 |
| 107 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.94714680 |
| 108 | Symptomatic seizures (HP:0011145) | 1.94505626 |
| 109 | Hand muscle atrophy (HP:0009130) | 1.94173837 |
| 110 | Hyperammonemia (HP:0001987) | 1.93358588 |
| 111 | Late onset (HP:0003584) | 1.93304684 |
| 112 | Mucopolysacchariduria (HP:0008155) | 1.93051594 |
| 113 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.93051594 |
| 114 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.92924059 |
| 115 | Gowers sign (HP:0003391) | 1.91968747 |
| 116 | Cerebral aneurysm (HP:0004944) | 1.91145827 |
| 117 | Esophageal varix (HP:0002040) | 1.90702726 |
| 118 | Sensorimotor neuropathy (HP:0007141) | 1.90385478 |
| 119 | Impaired social interactions (HP:0000735) | 1.90223881 |
| 120 | Abnormal social behavior (HP:0012433) | 1.90223881 |
| 121 | Tetraparesis (HP:0002273) | 1.88181207 |
| 122 | Retinal atrophy (HP:0001105) | 1.88099758 |
| 123 | Status epilepticus (HP:0002133) | 1.87732893 |
| 124 | Macroorchidism (HP:0000053) | 1.87653820 |
| 125 | Asymmetric septal hypertrophy (HP:0001670) | 1.87613762 |
| 126 | Back pain (HP:0003418) | 1.87344426 |
| 127 | Postural tremor (HP:0002174) | 1.87179219 |
| 128 | Hyperglycinuria (HP:0003108) | 1.87154658 |
| 129 | Neurofibrillary tangles (HP:0002185) | 1.86942211 |
| 130 | Increased circulating renin level (HP:0000848) | 1.85932562 |
| 131 | Rapidly progressive (HP:0003678) | 1.85679666 |
| 132 | Long toe (HP:0010511) | 1.84421169 |
| 133 | Abnormality of the fingertips (HP:0001211) | 1.83580278 |
| 134 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.83087366 |
| 135 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.83087366 |
| 136 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.83087366 |
| 137 | Epidermoid cyst (HP:0200040) | 1.82121515 |
| 138 | Increased purine levels (HP:0004368) | 1.81426719 |
| 139 | Hyperuricemia (HP:0002149) | 1.81426719 |
| 140 | Hypercortisolism (HP:0001578) | 1.81236226 |
| 141 | Absent phalangeal crease (HP:0006109) | 1.80237579 |
| 142 | Absence seizures (HP:0002121) | 1.79438390 |
| 143 | Dysostosis multiplex (HP:0000943) | 1.78482685 |
| 144 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.77626022 |
| 145 | Abnormality of the common coagulation pathway (HP:0010990) | 1.77270656 |
| 146 | Abnormal gallbladder morphology (HP:0012437) | 1.76770340 |
| 147 | Tetraplegia (HP:0002445) | 1.76526408 |
| 148 | Foot dorsiflexor weakness (HP:0009027) | 1.76382193 |
| 149 | Clonus (HP:0002169) | 1.74669129 |
| 150 | Cholelithiasis (HP:0001081) | 1.74620968 |
| 151 | Frequent falls (HP:0002359) | 1.74364475 |
| 152 | Microglossia (HP:0000171) | 1.74028321 |
| 153 | Papillary thyroid carcinoma (HP:0002895) | 1.73520942 |
| 154 | Dysdiadochokinesis (HP:0002075) | 1.72564139 |
| 155 | Anxiety (HP:0000739) | 1.72018733 |
| 156 | Abnormality of the foot musculature (HP:0001436) | 1.71390911 |
| 157 | Increased CSF protein (HP:0002922) | 1.70947278 |
| 158 | Increased cerebral lipofuscin (HP:0011813) | 1.70868859 |
| 159 | Difficulty climbing stairs (HP:0003551) | 1.70634272 |
| 160 | Neonatal onset (HP:0003623) | 1.69087101 |
| 161 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.69005970 |
| 162 | Malignant hyperthermia (HP:0002047) | 1.68955168 |
| 163 | Hyperkalemia (HP:0002153) | 1.68908243 |
| 164 | Hamartoma of the eye (HP:0010568) | 1.68488196 |
| 165 | Multiple enchondromatosis (HP:0005701) | 1.68081290 |
| 166 | Abnormality of glycine metabolism (HP:0010895) | 1.67606874 |
| 167 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.67606874 |
| 168 | Lymphangioma (HP:0100764) | 1.67586647 |
| 169 | Insomnia (HP:0100785) | 1.67447629 |
| 170 | Deformed tarsal bones (HP:0008119) | 1.66790974 |
| 171 | Myocardial infarction (HP:0001658) | 1.63101774 |
| 172 | Abnormal finger flexion creases (HP:0006143) | 1.61979242 |
| 173 | Agnosia (HP:0010524) | 1.60632962 |
| 174 | Limb-girdle muscle atrophy (HP:0003797) | 1.56572054 |
| 175 | Ventricular arrhythmia (HP:0004308) | 1.56426983 |
| 176 | Basal ganglia calcification (HP:0002135) | 1.55055318 |
| 177 | Abnormality of the salivary glands (HP:0010286) | 1.50129033 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 5.70760321 |
| 2 | TRIB3 | 3.59747091 |
| 3 | PRKD3 | 2.63469877 |
| 4 | PKN2 | 2.45774182 |
| 5 | KSR2 | 2.45291179 |
| 6 | NTRK3 | 2.33140499 |
| 7 | MAP3K13 | 2.26093603 |
| 8 | MAP3K9 | 2.25325572 |
| 9 | MOS | 2.15195133 |
| 10 | TGFBR2 | 2.14638938 |
| 11 | MAP3K2 | 2.08993454 |
| 12 | RIPK1 | 2.05508065 |
| 13 | EPHA4 | 1.99427452 |
| 14 | NTRK1 | 1.88872205 |
| 15 | DAPK2 | 1.86363565 |
| 16 | CAMKK1 | 1.83832244 |
| 17 | MAP2K3 | 1.74719472 |
| 18 | WNK4 | 1.73960520 |
| 19 | PDK4 | 1.71705037 |
| 20 | PDK3 | 1.71705037 |
| 21 | PAK6 | 1.70434637 |
| 22 | INSRR | 1.69383804 |
| 23 | LIMK1 | 1.68487623 |
| 24 | NEK9 | 1.67395274 |
| 25 | MAP3K4 | 1.65807754 |
| 26 | LMTK2 | 1.65689480 |
| 27 | NEK1 | 1.63672202 |
| 28 | PDGFRA | 1.63593522 |
| 29 | RET | 1.62998916 |
| 30 | SCYL2 | 1.61041115 |
| 31 | MAP2K4 | 1.54264632 |
| 32 | IRAK3 | 1.52724681 |
| 33 | TRPM7 | 1.51035017 |
| 34 | TTN | 1.48087951 |
| 35 | MAP3K12 | 1.41484913 |
| 36 | FRK | 1.41156302 |
| 37 | PIK3CG | 1.40642329 |
| 38 | MINK1 | 1.39059036 |
| 39 | CAMKK2 | 1.38033308 |
| 40 | EIF2AK1 | 1.37139926 |
| 41 | PTK6 | 1.35970845 |
| 42 | FGFR4 | 1.35965425 |
| 43 | ARAF | 1.34889075 |
| 44 | PBK | 1.33177610 |
| 45 | TYRO3 | 1.33159955 |
| 46 | PRKCH | 1.29580063 |
| 47 | CAMK1G | 1.29128537 |
| 48 | SIK1 | 1.28207033 |
| 49 | STK38 | 1.27691390 |
| 50 | PRPF4B | 1.27593829 |
| 51 | BCKDK | 1.27246689 |
| 52 | EIF2AK3 | 1.22457747 |
| 53 | PHKG1 | 1.21472439 |
| 54 | PHKG2 | 1.21472439 |
| 55 | NME2 | 1.19316150 |
| 56 | MAP3K1 | 1.17998204 |
| 57 | RPS6KB2 | 1.16961259 |
| 58 | CAMK1D | 1.16647286 |
| 59 | WNK1 | 1.16273326 |
| 60 | ERN1 | 1.11047218 |
| 61 | FER | 1.10355708 |
| 62 | GRK7 | 1.08932116 |
| 63 | PDPK1 | 1.08308778 |
| 64 | PDK1 | 1.04828965 |
| 65 | EEF2K | 1.04722991 |
| 66 | STK24 | 1.04679703 |
| 67 | MUSK | 1.02647867 |
| 68 | MST4 | 1.00839117 |
| 69 | PAK3 | 0.98597662 |
| 70 | MYLK | 0.97735495 |
| 71 | PAK4 | 0.93951431 |
| 72 | MAP3K7 | 0.93113835 |
| 73 | DMPK | 0.91982706 |
| 74 | TAOK1 | 0.91971627 |
| 75 | FGFR2 | 0.91183164 |
| 76 | MAP3K3 | 0.91133212 |
| 77 | ALK | 0.87931845 |
| 78 | RIPK4 | 0.87683972 |
| 79 | SGK3 | 0.87596337 |
| 80 | PTK2 | 0.86178551 |
| 81 | BRAF | 0.85996454 |
| 82 | KSR1 | 0.83929603 |
| 83 | CDK5 | 0.83750149 |
| 84 | TAOK3 | 0.83680068 |
| 85 | PDK2 | 0.80064265 |
| 86 | MAPK12 | 0.78801479 |
| 87 | STK11 | 0.77263350 |
| 88 | MAP2K1 | 0.75190023 |
| 89 | JAK2 | 0.74762884 |
| 90 | SGK494 | 0.74450932 |
| 91 | SGK223 | 0.74450932 |
| 92 | PRKAA2 | 0.73896686 |
| 93 | FGFR3 | 0.73702534 |
| 94 | CDK6 | 0.73371415 |
| 95 | PIK3CA | 0.73288853 |
| 96 | PINK1 | 0.72087508 |
| 97 | LATS1 | 0.70311592 |
| 98 | EPHA2 | 0.70224746 |
| 99 | FGR | 0.68654449 |
| 100 | CSF1R | 0.67897831 |
| 101 | AKT2 | 0.67605302 |
| 102 | JAK1 | 0.66373075 |
| 103 | ILK | 0.65949217 |
| 104 | PRKD1 | 0.65648456 |
| 105 | TIE1 | 0.64612597 |
| 106 | EPHB1 | 0.64209201 |
| 107 | PRKAA1 | 0.64197093 |
| 108 | STK3 | 0.62520387 |
| 109 | MST1R | 0.61153815 |
| 110 | WNK3 | 0.61094149 |
| 111 | PDGFRB | 0.60925658 |
| 112 | LATS2 | 0.60453839 |
| 113 | ROCK1 | 0.60445454 |
| 114 | MAP3K14 | 0.60232356 |
| 115 | STK38L | 0.60039035 |
| 116 | STK10 | 0.59575505 |
| 117 | CDC42BPA | 0.59009941 |
| 118 | MAPKAPK3 | 0.58303417 |
| 119 | MAP3K10 | 0.58156961 |
| 120 | PTK2B | 0.58123643 |
| 121 | NTRK2 | 0.57952405 |
| 122 | STK39 | 0.57395815 |
| 123 | NEK6 | 0.56673889 |
| 124 | DDR2 | 0.55682275 |
| 125 | RPS6KB1 | 0.52103620 |
| 126 | GRK5 | 0.51232960 |
| 127 | HIPK2 | 0.50936626 |
| 128 | CAMK2D | 0.50347500 |
| 129 | MAP2K6 | 0.49737360 |
| 130 | MAP3K8 | 0.48328750 |
| 131 | EPHA3 | 0.48263205 |
| 132 | ERBB3 | 0.47637967 |
| 133 | ABL2 | 0.47370208 |
| 134 | SGK1 | 0.45718809 |
| 135 | TTK | 0.45183505 |
| 136 | RPS6KA3 | 0.44847625 |
| 137 | TESK1 | 0.43514147 |
| 138 | MARK2 | 0.43333410 |
| 139 | PRKCG | 0.42359266 |
| 140 | BMX | 0.41737200 |
| 141 | PRKACG | 0.41370591 |
| 142 | UHMK1 | 0.41339937 |
| 143 | MTOR | 0.41198820 |
| 144 | RAF1 | 0.40115234 |
| 145 | ICK | 0.39935679 |
| 146 | LRRK2 | 0.39809118 |
| 147 | OXSR1 | 0.39677872 |
| 148 | ROCK2 | 0.39280866 |
| 149 | DAPK1 | 0.39202352 |
| 150 | PRKCZ | 0.39147989 |
| 151 | SGK2 | 0.38747771 |
| 152 | CAMK2G | 0.38657058 |
| 153 | MET | 0.38614890 |
| 154 | DAPK3 | 0.37547717 |
| 155 | PRKG2 | 0.34748114 |
| 156 | BMPR2 | 0.33873867 |
| 157 | MAP3K6 | 0.33677344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.80295964 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.85422595 |
| 3 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.68032332 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.52125263 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.38962675 |
| 6 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.99719824 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.96530140 |
| 8 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.95239004 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.82864626 |
| 10 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.77120352 |
| 11 | Galactose metabolism_Homo sapiens_hsa00052 | 1.60791554 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.55386956 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52328738 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.51853796 |
| 15 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.50963226 |
| 16 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.49745600 |
| 17 | Bile secretion_Homo sapiens_hsa04976 | 1.49653116 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.45579399 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.43784186 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.42468815 |
| 21 | Thyroid cancer_Homo sapiens_hsa05216 | 1.41330052 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.39862997 |
| 23 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.38899427 |
| 24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.38488628 |
| 25 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.38174866 |
| 26 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.37829196 |
| 27 | Long-term potentiation_Homo sapiens_hsa04720 | 1.35741244 |
| 28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.29055720 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.27981099 |
| 30 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.27395391 |
| 31 | Adherens junction_Homo sapiens_hsa04520 | 1.24568669 |
| 32 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.24541659 |
| 33 | GABAergic synapse_Homo sapiens_hsa04727 | 1.22160643 |
| 34 | Amoebiasis_Homo sapiens_hsa05146 | 1.17906066 |
| 35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.17228597 |
| 36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.16909824 |
| 37 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.16776269 |
| 38 | Circadian rhythm_Homo sapiens_hsa04710 | 1.16646771 |
| 39 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.16397243 |
| 40 | Focal adhesion_Homo sapiens_hsa04510 | 1.16281565 |
| 41 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.14027907 |
| 42 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.11650763 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.10420905 |
| 44 | Circadian entrainment_Homo sapiens_hsa04713 | 1.10410825 |
| 45 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.09143939 |
| 46 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.08172892 |
| 47 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.06293884 |
| 48 | Renin secretion_Homo sapiens_hsa04924 | 1.05781098 |
| 49 | Tight junction_Homo sapiens_hsa04530 | 1.05161404 |
| 50 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.04074965 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.02923517 |
| 52 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.02716585 |
| 53 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.02682415 |
| 54 | Olfactory transduction_Homo sapiens_hsa04740 | 1.01753883 |
| 55 | Endometrial cancer_Homo sapiens_hsa05213 | 1.01312786 |
| 56 | Cocaine addiction_Homo sapiens_hsa05030 | 1.00595869 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.00204752 |
| 58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.00201994 |
| 59 | Salivary secretion_Homo sapiens_hsa04970 | 0.99727162 |
| 60 | Insulin resistance_Homo sapiens_hsa04931 | 0.97309366 |
| 61 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.95868882 |
| 62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.93312426 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.93270836 |
| 64 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.91569514 |
| 65 | Carbon metabolism_Homo sapiens_hsa01200 | 0.90703272 |
| 66 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.89316384 |
| 67 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.89215992 |
| 68 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.88435370 |
| 69 | Morphine addiction_Homo sapiens_hsa05032 | 0.87453269 |
| 70 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.87275969 |
| 71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86483464 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86102614 |
| 73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.85965009 |
| 74 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.85735362 |
| 75 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.85211238 |
| 76 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.85024147 |
| 77 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.84815570 |
| 78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84483799 |
| 79 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.83012492 |
| 80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.83006476 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.82798965 |
| 82 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82685524 |
| 83 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.82314957 |
| 84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.80978644 |
| 85 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.80121252 |
| 86 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.79806090 |
| 87 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.78839443 |
| 88 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.77395278 |
| 89 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.76918767 |
| 90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.76731506 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.76625028 |
| 92 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76573869 |
| 93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76370913 |
| 94 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.75749908 |
| 95 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.72874171 |
| 96 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72287368 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.70308346 |
| 98 | Platelet activation_Homo sapiens_hsa04611 | 0.69709574 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.69050670 |
| 100 | Glioma_Homo sapiens_hsa05214 | 0.68674996 |
| 101 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.67742023 |
| 102 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.66973591 |
| 103 | Mineral absorption_Homo sapiens_hsa04978 | 0.66888045 |
| 104 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.66120275 |
| 105 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.65860082 |
| 106 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.65240053 |
| 107 | Nicotine addiction_Homo sapiens_hsa05033 | 0.64306019 |
| 108 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.63918680 |
| 109 | Gap junction_Homo sapiens_hsa04540 | 0.63849896 |
| 110 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.62541587 |
| 111 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61876759 |
| 112 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.61691506 |
| 113 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60233454 |
| 114 | Bladder cancer_Homo sapiens_hsa05219 | 0.59979208 |
| 115 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.59744657 |
| 116 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59562121 |
| 117 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59270556 |
| 118 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.59035139 |
| 119 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.58868944 |
| 120 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.57927545 |
| 121 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56169131 |
| 122 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55902820 |
| 123 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55255836 |
| 124 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.54847924 |
| 125 | Legionellosis_Homo sapiens_hsa05134 | 0.54398245 |
| 126 | Prion diseases_Homo sapiens_hsa05020 | 0.54350014 |
| 127 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.54091983 |
| 128 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54072912 |
| 129 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.53680010 |
| 130 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.53544135 |
| 131 | Lysosome_Homo sapiens_hsa04142 | 0.53171269 |
| 132 | Peroxisome_Homo sapiens_hsa04146 | 0.53007205 |
| 133 | Long-term depression_Homo sapiens_hsa04730 | 0.51359695 |
| 134 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51160251 |
| 135 | Histidine metabolism_Homo sapiens_hsa00340 | 0.51154659 |
| 136 | Endocytosis_Homo sapiens_hsa04144 | 0.51090371 |
| 137 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50718744 |
| 138 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.50124130 |
| 139 | Prostate cancer_Homo sapiens_hsa05215 | 0.49519697 |
| 140 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.49205450 |
| 141 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48494832 |
| 142 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47611302 |
| 143 | Lysine degradation_Homo sapiens_hsa00310 | 0.47549742 |
| 144 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.45839132 |
| 145 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.45691317 |
| 146 | Taste transduction_Homo sapiens_hsa04742 | 0.45513279 |
| 147 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44515888 |
| 148 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44426898 |
| 149 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44418530 |

